Serological survey of the novel influenza A H1N1 in inner city Winnipeg, Manitoba, 2009

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 23, Issue 2, 2012, Pages 65-70

  Thompson, Laura H ^a   Mahmud, Salaheddin M ^a   Keynan, Yoav ^a   Blanchard, James F ^a   Slater, Joyce ^a   Dawood, Magdy ^a,b   Fowke, Keith ^a   Van Caeseele, Paul ^a,b   Becker, Marissa ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CADHAM PROVINCIAL LABORATORY   (Canada)

Author keywords

Epidemiology; Hemagglutination inhibition assay; Inner city; Pandemic influenza A H1N1; PH1N1; Serological survey

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

ABORIGINE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANADA; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; SEASONAL INFLUENZA; SEROPREVALENCE; SOCIOECONOMICS; STRUCTURED QUESTIONNAIRE; SYMPTOMATOLOGY;

EID: 84864854822     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/484693     Document Type: Article

References (26)

1. Cutler J, Schleihauf E, Hatchette T, et al. Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 2009;181:159-63.
2. CDC Branch, Manitoba Health. Influenza in Manitoba - 2008/2009 Season. July 1, 2009. 〈www.gov.mb.ca/health/publichealth/surveillance/influenza/ 0809season.pdf〉 (Accessed July 19, 2010).
3. CDC Branch, Manitoba Health. Influenza in Manitoba - 2009/2010 Season. April 10, 2010. 〈www.gov.mb.ca/health/publichealth/surveillance/influenza/ 0910season.pdf〉 (Accessed July 19, 2010).
4. Embree J. Pandemic 2009 (A) H1N1 influenza (swine flu)-the Manitoba experience. Biochem Cell Biol 2010:88:589-93.
5. Public Health Agency of Canada. Flu Watch for September 6, 2009 to September 12, 2009 (Week 36). 〈www.phac-aspc.gc.ca/fluwatch/09-10/w36-09/ index-eng.php〉 (Accessed July 19, 2010).
6. Vlahov D, Coady M, Ompad D, Galea S. Strategies for improving influenza immunization rates among hard-to-reach populations. J Urban Health 2007;84:616-31.
7. Bryant WK, Ompad DC, Sisco S, et al. Determinants of influenza vaccination in hard-to-reach urban populations. Prev Med 2006;43:60-70. (Pubitemid 43947177)
8. Webster R, Cox N, Stohr K. WHO manual on animal influenza diagnosis and surveillance. World Health Organization, 2002.
9. Sandbulte M, Jimenez G, Boon A, Smith L, Treanor J, Webby R. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 2007;4:e59.
10. de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003;115:63-73.
11. Potter C, Oxford J. Determinants of immunity to influenza infection in man. Br Med Bull 1979;35:69-75. (Pubitemid 9096975)
12. Clopper C, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26:404-13.
13. Kunzel W, Glathe H, Engelmann H, Van Hoecke C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 1996;14:1108-10. (Pubitemid 26348827)
14. Mahmud SM, Becker M, Keynan Y, et al. Estimated cumulative incidence of pandemic (H1N1) influenza among pregnant women during the first wave of the 2009 pandemic. CMAJ 2010;182:1522-4.
15. Fiore AE, Neuzil KM. 2009 Influenza A(H1N1) monovalent vaccines for children. JAMA 2010;303:73-4.
16. Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: A randomized trial. JAMA 2010;303:943-50.
17. Public Health Agency of Canada. FluWatch. 〈http://origin.phac-aspc. gc.ca/fluwatch/〉 (Accessed July 19, 2010).
18. La Ruche G, Tarantola A, Barboza P, Vaillant L, Gueguen J, Gastellu-Etchegorry M, for the epidemic intelligence team at InVS. The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill 2009;14:19366.
19. Pollock SL, Sagan M, Oakley L, Fontaine J, Poffenroth L. Investigation of a pandemic H1N1 influenza outbreak in a remote First Nations community in northern Manitoba, 2009. Can J Public Health 2012;103:90-3.
20. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945-52.
21. Hardelid P, Andrews Ni, Hoschler K, et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza AH1N1 2009. Health Technol Assess 2010;14:115-92.
22. Manitoba Health and Healthy Living. Seasonal Flu. 〈www.gov.mb.ca/ health/flu/〉 (Accessed July 19, 2010).
23. Manitoba Health and Healthy Living. Media Bulletin. Flu Bulletin #2, October 21, 2009. 〈www.gov.mb.ca/chc/press/top/2009/10/2009-10-21-141700- 7026.html〉 (Accessed July 19, 2010).
24. Kwong JC, Rosella LC, Johansen H. Trends in influenza vaccination in Canada, 1996/1997 to 2005. Health Rep 2007;18:9-19.
25. Katz J, Hancock K, Veguilla V, et al. Serum cross-reactive Antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 2009;58:521-4.
26. Tosh PK, Jacobson RM, Poland GA. Influenza vaccines: From surveillance through production to protection. Mayo Clinic Proc 2010;85:257-73.